Cidara Therapeutics

📍 San Diego, United States🗓 Founded 2013👥 80 employees💰 Last funded Mar 2015
Cidara (NASDAQ: CDTX) is developing long-acting therapeutics to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in San Diego, California.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2013
Founded
Investor geography1 country
United States
3
Investor activity2014–2015 · investors recorded per year
2014220151
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cidara Therapeutics?
Cidara Therapeutics has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Cidara Therapeutics last raise funding?
The most recent investment in Cidara Therapeutics recorded on gritt.io was in March 2015.
When was Cidara Therapeutics founded?
Cidara Therapeutics was founded in 2013.
What industry is Cidara Therapeutics in?
Cidara Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cidara Therapeutics based?
Cidara Therapeutics is headquartered in San Diego, United States.